Cancer medicines

Palbociclib

Palbociclib

A CDK4/6-targeted therapy used with endocrine treatment.

Sources checked · Introductory guide

On this page

How it works

It inhibits cell-cycle regulators CDK4 and CDK6 to slow growth.[3]

Where it is used

Used with an aromatase inhibitor or fulvestrant in selected HR-positive, HER2-negative advanced breast cancers.[1]

Key safety points

Blood counts need monitoring. Report fever, chills, new cough or breathlessness immediately and follow the prescribed dosing and break schedule.[2]

Questions for your care team

  • What endocrine therapy, blood tests and treatment breaks are planned?

Sources and scope

Source documents are in English.

Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.

  1. NCI · Palbociclib (opens in a new tab)
  2. MedlinePlus · Palbociclib (opens in a new tab)
  3. NCI Drug Dictionary · Palbociclib (opens in a new tab)

General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.

Related entries

Palbociclib | Cancer Encyclopedia | My Chemo Diary